Psychiatric symptoms, associated pharmacological treatments and cognitive function: A population-based study of men
Journal of Affective Disorders · 2024
DOI: 10.1016/j.jad.2024.04.076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2024. Verfasst von Kayla B Corney und 6 weiteren Autor:innen. Beteiligte Einrichtung: Deakin University, IMPACT - Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Victoria, Australia. Elec…. Hauptthemen laut MEDLINE: Cognition, Psychotropic Drugs. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of New South Wales, Deakin University, National Health and Medical Research Council.
Abstract (Originalsprache)
BACKGROUND: Psychiatric symptomatology and medications used in their treatment may be modifiable risk factors associated with cognitive function, although findings from population-based studies spanning the full adult age range are lacking. This study aimed to investigate associations between psychiatric symptomatology, psychotropic medication use and cognitive function in a population-based sample of men. METHODS: Data for 537 men were drawn from the Geelong Osteoporosis Study. Cognitive function (psychomotor function, attention, working memory and visual learning) was determined using the Cog-State Brief Battery. Current depressive and anxiety symptomatology was determined using the Hospital Anxiety and Depression Scale, and psychotropic medication use was self-reported. Linear regression models were developed to determine associations between psychiatric symptomatology and psychotropic medication use with each cognitive measure. RESULTS: Depressive symptomatology was associated with lower overall cognitive function (b-0.037 ± 0.010, η2 = 0.025, p < 0.001), psychomotor function (b 0.006 ± 0.002, η2 = 0.028 p < 0.001) and attention (b 0.004 ± 0.001, η2 = 0.021, p < 0.001), whereas psychotropic use was associated with lower overall cognitive function (b - 0.174 ± 0.075, η2 = 0.010, p = 0.021), attention (b 0.017 ± 0.008, η2 = 0.008, p = 0.038 and working memory (b 0.031 ± 0.012, η2 = 0.010, p = 0.010). Anticonvulsant use was associated with lower overall cognitive function (b - 0.723 ± 0.172, η2 = 0.032, p < 0.001), attention (b 0.065 ± 0.018, η2 = 0.029, p < 0.001) and working memory (b 0.088 ± 0.026, η2 = 0.022, p < 0.001). All relationships were found to have a small effect. There were no significant associations between anxiety symptomatology and antidepressant and anxiolytic use with any of the cognitive domains. CONCLUSION: Depressive symptomatology and anticonvulsant use were associated with lower cognitive function. Understanding the underlying mechanisms involved in these relationships can advance knowledge on the heterogeneity in cognitive ageing and aid in prevention initiatives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Deakin University, IMPACT - Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Victoria, Australia. Electronic address: corneyk@deakin.edu.au.
- Deakin University, IMPACT - Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Victoria, Australia.
- Deakin University, IMPACT - Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Victoria, Australia; Barwon Health, Geelong, VIC, Australia; Department of Medicine-Western Hea…
- Deakin University, IMPACT - Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Victoria, Australia; Deakin University, Faculty of Health, Biostatistics Unit, Melbourne, VIC,…
- Deakin University, IMPACT - Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Victoria, Australia; Deakin University, Deakin Rural Health, School of Medicine, Warrnambool, V…
- Deakin University, IMPACT - Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Victoria, Australia; Barwon Health, Geelong, VIC, Australia.
Förderung
- University of New South Wales
- Deakin University
- National Health and Medical Research Council
- Cancer Council Victoria
- Australian Rotary Health Research Fund
Zitieren
APA
Corney, K. B., Stuart, A. L., Pasco, J. A., Mohebbi, M., Kavanagh, B. E., Sui, S. X., & Williams, L. J. (2024). Psychiatric symptoms, associated pharmacological treatments and cognitive function: A population-based study of men. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.04.076
Vancouver
Corney KB, Stuart AL, Pasco JA, Mohebbi M, Kavanagh BE, Sui SX, et al. Psychiatric symptoms, associated pharmacological treatments and cognitive function: A population-based study of men. Journal of Affective Disorders. 2024. doi:10.1016/j.jad.2024.04.076
BibTeX
@article{Corney2024,
author = {Corney, Kayla B and Stuart, Amanda L and Pasco, Julie A and Mohebbi, Mohammadreza and Kavanagh, Bianca E and Sui, Sophia X and Williams, Lana J},
title = {Psychiatric symptoms, associated pharmacological treatments and cognitive function: A population-based study of men},
journal = {Journal of Affective Disorders},
year = {2024},
doi = {10.1016/j.jad.2024.04.076}
}
EUVIMED